APA (7th ed.) Citation

Aberger, S., Aberger, S., Schuller, M., Mooslechner, A. A., Mooslechner, A. A., Klötzer, K. A., . . . Eller, K. (2025). T cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation – An Observational Cohort Study. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Aberger, Simon, et al. T Cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation – An Observational Cohort Study. Frontiers Media S.A, 2025.

MLA (9th ed.) Citation

Aberger, Simon, et al. T Cell Activation Marker HLA-DR Reflects Tacrolimus-Associated Immunosuppressive Burden and BK Viremia Risk After Kidney Transplantation – An Observational Cohort Study. Frontiers Media S.A, 2025.